Candida glabrata Binding to Candida albicans Hyphae Enables Its Development in Oropharyngeal Candidiasis

PLoS Pathogens

Volumn 12, Issue 3, 2016, Pages

  Tati, Swetha ^a   Davidow, Peter ^a   McCall, Andrew ^a   Hwang Wong, Elizabeth ^b   Rojas, Isolde G ^a   Cormack, Brendan ^b   Edgerton, Mira ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDA GLABRATA; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; FUNGAL COLONIZATION; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS HYPHAE; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; OROPHARYNX CANDIDIASIS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; SCANNING ELECTRON MICROSCOPY; ANIMAL; CELL WALL; DRUG EFFECTS; METABOLISM; MICROBIOLOGY; MIXED INFECTION; PATHOGENICITY; THRUSH;

ANIMALS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS, ORAL; CELL WALL; COINFECTION; FEMALE; FLUCONAZOLE; HYPHAE; MICE;

EID: 84962356047     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005522     Document Type: Article

References (56)

1. Belazi M, Velegraki A, Koussidou-Eremondi T, et al. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment. Oral Microbiol Immunol. 2004;19:347–351. 15491459
2. Dongari-Bagtzoglou A, Dwivedi P, Ioannidou E, Shaqman M, Hull D, Burleson J, Oral Candida infection and colonization in solid organ transplant recipients. Oral Microbiol Immunol. 2009;24:249–254. doi: 10.1111/j.1399-302X.2009.00505.x19416456
3. Fidel PL, Jr.Vazquez JA, Sobel JD, Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. 1999;12:80–96. 9880475
4. Redding SW, Kirkpatrick WR, Coco BJ, et al. Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer. J Clin Microbiol. 2002;40:1879–1881. 11980984
5. Vazquez JA, Options for the management of mucosal candidiasis in patients with AIDS and HIV infection. Pharmacotherapy. 1999;19:76–87. 9917080
6. Redding SW, Zellars RC, Kirkpatrick WR, et al. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol. 1999;37:3896–3900. 10565903
7. Redding SW, The role of yeasts other than Candida albicans in oropharyngeal candidiasis. Curr Opin Infect Dis. 2001;14:673–677. 11964883
8. Fonseca E, Silva S, Rodrigues CF, Alves CT, Azeredo J, Henriques M, Effects of fluconazole on Candida glabrata biofilms and its relationship with ABC transporter gene expression. Biofouling. 2014;30:447–457. doi: 10.1080/08927014.2014.88610824645630
9. Maldonado NA, Cano LE, De Bedout C, Arbelaez CA, Roncancio G, Tabares AM, et al. Association of clinical and demographic factors in invasive candidiasis caused by fluconazole-resistant Candida species: a study in 15 hospitals, Medellin, Colombia 2010–2011. Diagn Microbiol Infect Dis. 2014;79:280–286. doi: 10.1016/j.diagmicrobio.2014.02.00324666706
10. Gow NA, Brown AJ, Odds FC, Fungal morphogenesis and host invasion. Curr Opin Microbiol. 2002;5:366–371. 12160854
11. Sudbery PE, Growth of Candida albicans hyphae. Nat Rev Microbiol. 2011;9:737–748. doi: 10.1038/nrmicro263621844880
12. Moyes DL, Richardson JP, Naglik JR, Candida albicans-epithelial interactions and pathogenicity mechanisms: Scratching the surface. Virulence. 2015:0.
13. de Groot PW, Bader O, de Boer AD, Weig M, Chauhan N, Adhesins in human fungal pathogens: glue with plenty of stick. Eukaryot Cell. 2013;12:470–481. doi: 10.1128/EC.00364-1223397570
14. Liu Y, Filler SG, Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryot Cell. 2011;10:168–173. doi: 10.1128/EC.00279-1021115738
15. Hoyer LL, The ALS gene family of Candida albicans. Trends Microbiol. 2001;9:176–180. 11286882
16. Cavalcanti YW, Morse DJ, da Silva WJ, et al. Virulence and pathogenicity of Candida albicans is enhanced in biofilms containing oral bacteria. Biofouling. 2015;31:27–38. doi: 10.1080/08927014.2014.99614325574582
17. Silverman RJ, Nobbs AH, Vickerman MM, Barbour ME, Jenkinson HF, Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixed-species communities. Infect Immun. 2010;78:4644–4652. doi: 10.1128/IAI.00685-1020805332
18. Peters BM, Ovchinnikova ES, Krom BP, et al. Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p. Microbiology. 2012;158(Pt 12):2975–2986. doi: 10.1099/mic.0.062109-022918893
19. Mear JB, Kipnis E, Faure E, et al. Candida albicans and Pseudomonas aeruginosa interactions: more than an opportunistic criminal association?Med Mal Infect. 2013;43:146–151. doi: 10.1016/j.medmal.2013.02.00523622953
20. Riera M, Mogensen E, d'Enfert C, Janbon G, New regulators of biofilm development in Candida glabrata. Res Microbiol. 2012;163:297–307. doi: 10.1016/j.resmic.2012.02.00522426249
21. Kaur R, Domergue R, Zupancic ML, Cormack BP, A yeast by any other name: Candida glabrata and its interaction with the host. Curr Opin Microbiol. 2005;8:378–384. 15996895
22. Cormack BP, Ghori N, Falkow S, An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science. 1999;285:578–582. 10417386
23. Castano I, Pan SJ, Zupancic M, Hennequin C, Dujon B, Cormack BP, Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata. Mol Microbiol. 2005;55:1246–1258. 15686568
24. Elias S, Banin E, Multi-species biofilms: living with friendly neighbors. FEMS Microbiol Rev. 2012;36:990–1004. doi: 10.1111/j.1574-6976.2012.00325.x22229800
25. Boon C, Deng Y, Wang LH, et al. A novel DSF-like signal from Burkholderia cenocepacia interferes with Candida albicans morphological transition. ISME J. 2008;2:27–36. 18049456
26. Vale-Silva L, Ischer F, Leibundgut-Landmann S, Sanglard D, Gain-of-function mutations in PDR1, a regulator of antifungal drug resistance in Candida glabrata, control adherence to host cells. Infect Immun. 2013;81:1709–1720. doi: 10.1128/IAI.00074-1323460523
27. Brothers KM, Newman ZR, Wheeler RT, Live imaging of disseminated candidiasis in Zebrafish reveals role of phagocyte oxidase in limiting filamentous Growth. Eukaryot Cell. 2011;10:932–944. doi: 10.1128/EC.05005-1121551247
28. Heilmann CJ, Sorgo AG, Siliakus AR, et al. Hyphal induction in the human fungal pathogen Candida albicans reveals a characteristic wall protein profile. Microbiology. 2011;157:2297–2307. doi: 10.1099/mic.0.049395-021602216
29. Puri S, Kumar R, Chadha S, Tati S, Conti HR, Hube B, et al. Secreted aspartic protease cleavage of Candida albicans Msb2 activates Cek1 MAPK signaling affecting biofilm formation and oropharyngeal candidiasis. PLoS ONE. 2012; 7(11): e46020. doi: 10.1371/journal.pone.004602023139737
30. Alves CT, Wei XQ, Silva S, Azeredo J, Henriques M, Williams DW, Candida albicans promotes invasion and colonization of Candida glabrata in a reconstituted human vaginal epithelium. J Infect. 2014; 69:396–407. doi: 10.1016/j.jinf.2014;06.00224924556.
31. Schaller M, Mailhammer R, Grassl G, Sander CA, Hube B, et al. Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol. 2002; 118: 652–65711918712
32. Silva S, Henriques M, Hayes A, Oliveira R, Azeredo J, Williams DW, Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium. J Oral Pathol Med. 2011;40:421–427. doi: 10.1111/j.1600-0714.2010.00981.x21158929
33. Rossoni RD, Barbosa JO, Vilela SFG, dos Santos JD, de Barros PP, Prata MCdA, et al. Competitive Interactions between C. albicans, C. glabrata and C. krusei during biofilm formation and development of experimental candidiasis. PLoS ONE. 2015; 10(7): e0131700. doi: 10.1371/journal.pone.013170026146832
34. Westwater C, Schofield DA, Nicholas PJ, Paulling EE, Balish E, Candida glabrata and Candida albicans; dissimilar tissue tropism and infectivity in a gnotobiotic model of mucosal candidiasis. Fems Immunol Medl Microbiol. 2007; 51: 134–139.
35. Li L, Kashleva H, Dongari-Bagtzoglou A, Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models. Microb Pathog. 2007; 42:138–147. 17306958
36. Bamford CV, Nobbs AH, Barbour ME, Lamont RJ, Jenkinson HF, Functional regions of Candida albicans hyphal cell wall protein Als3 that determine interaction with the oral bacterium Streptococcus gordonii. Microbiology. 2015;161(Pt 1):18–29. doi: 10.1099/mic.0.083378-025332379
37. Peters BM, Ovchinnikova ES, Krom BP, Schlecht LM, Zhou H, Hoyer LL, et al. Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p. Microbiology2012; 158: 2975–2986. doi: 10.1099/mic.0.062109-022918893
38. Martinez-Jimenez V, Ramirez-Zavaleta CY, Orta-Zavalza E, et al. Sir3 Polymorphisms in Candida glabrata clinical isolates. Mycopathologia. 2013;175(3–4):207–219. doi: 10.1007/s11046-013-9627-223392823
39. Maestre-Reyna M, Diderrich R, Veelders MS, Eulenburg G, Kalugin V, et al. Structural basis for promiscuity and specificity during Candida glabrata invasion of host epithelia. Proc Natl Acad Sci. 2012; 109: 16864–16869. doi: 10.1073/pnas.120765310923035251
40. Diderrich R, Kock M, Reyna MM, Keller P, Steuber H, et al. Structural hot spots determine functional diversity of the Candida glabrata epithelial adhesin family. J Biol Chem. 2015; 290: 19597–19613. doi: 10.1074/jbc.M115.65565426105055
41. Zupancic ML, Frieman M, Smith D, Alvarez RA, Cummings RD, Cormack BP, Glycan microarray analysis of Candida glabrata adhesin ligand specificity. Mol Microbiol. 2008;68:547–559. doi: 10.1111/j.1365-2958.2008.06184.x18394144
42. Gallegos-Garcia V, Pan SJ, Juarez-Cepeda J, et al. A novel downstream regulatory element cooperates with the silencing machinery to repress EPA1 expression in Candida glabrata. Genetics. 2012;190:1285–1297. doi: 10.1534/genetics.111.13809922234857
43. Richard ML, Nobile CJ, Bruno VM, Mitchell AP, Candida albicans biofilm-defective mutants. Eukaryot Cell. 2005;4:1493–1502. 16087754
44. Puri S, Lai WK, Rizzo JM, Buck MJ, Edgerton M, Iron-responsive chromatin remodelling and MAPK signalling enhance adhesion in Candida albicans. Mol Microbiol. 2014;93:291–305. doi: 10.1111/mmi.1265924889932
45. Brothers KM, Newman ZR, Wheeler RT, Live imaging of disseminated candidiasis in zebrafish reveals role of phagocyte oxidase in limiting filamentous growth. Eukaryot Cell. 2011;10:932–944. doi: 10.1128/EC.05005-1121551247
46. Vale-Silva L, Ischer F, Leibundgut-Landmann S, Sanglard D, Gain-of-function mutations in PDR1, a regulator of antifungal drug resistance in Candida glabrata, control adherence to host cells. Infect Immun. 2013;81:1709–1720. doi: 10.1128/IAI.00074-1323460523
47. Kumar R, Saraswat D, Tati S, Edgerton M, Novel aggregation properties of Candida albicans secreted aspartyl proteinase Sap6 mediates virulence in oral candidiasis. Infect Immun. 2015;83:2614–2626. 25870228
48. Tati S, Li R, Puri S, Kumar R, Davidow P, Edgerton M, Histatin 5-spermidine conjugates have enhanced fungicidal activity and efficacy as a topical therapeutic for oral candidiasis. Antimicrob Agents Chemother. 2014;58(2):756–766. doi: 10.1128/AAC.01851-1324247141
49. Fonzi WA, Irwin MY, Isogenic strain construction and gene mapping in Candida albicans. Genetics. Jul1993;134(3):717–728.
50. Davis D, Edwards JE, JrMitchell AP, Ibrahim AS, Candida albicans RIM101 pH response pathway is required for host-pathogen interactions. Infect Immun. 2000; 68:5953–5959. 10992507
51. Coste AT, Karababa M, Ischer F, Bille J, Sanglard D, TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell. 2004;3:1639–1652. 15590837
52. Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, Phan QT, et al. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog. 2006;2(7):e63doi: 10.1371/journal.ppat.002006316839200.
53. Fu Y, Ibrahim AS, Sheppard DC, Chen YC, French SW, Cutler JE, et al. Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway. Mol Microbiol. 2002;44:61–72. 11967069
54. Nobile CJ, Schneider HA, Nett JE, Sheppard DC, Filler SG, Andes DR, et al. Complementary adhesin function in C. albicans biofilm formation. Curr Biol. 2008;18:1017–1024. doi: 10.1016/j.cub.2008.06.03418635358
55. Sheppard DC, Yeaman MR, Welch WH, et al. Functional and structural diversity in the Als protein family of Candida albicans. J Biol Chem. 2004;279:30480–30489. 15128742
56. Sanglard D, Coste A, Ferrari S, Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res. 2009;9:1029–1050. doi: 10.1111/j.1567-1364.2009.00578.x19799636